Yuejun Du
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
MicroRNA-24-3p targeting Top1 in perirenal fat is involved in circulating inflammation and high cardiovascular disease risk in patients with primary aldosteronism.
Journal: Journal of translational medicine
Published: October 05, 2024
Chimeric SFT2D2-TBX19 Promotes Prostate Cancer Progression by Encoding TBX19-202 Protein and Stabilizing Mitochondrial ATP Synthase through ATP5F1A Phosphorylation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 23, 2024
GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR-driven transcriptional activation.
Journal: Journal of cellular and molecular medicine
Published: May 20, 2024
Propranolol can correct prolonged QT intervals in patients with cirrhosis.
Journal: Frontiers in pharmacology
Published: January 14, 2024
Long noncoding RNA XIST regulates brown preadipocytes differentiation and combats high-fat diet induced obesity by targeting C/EBPα.
Journal: Molecular medicine (Cambridge, Mass.)
Published: October 22, 2021
The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials.
Journal: Aging
Published: December 01, 2020
Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy.
Journal: Oncotarget
Published: March 16, 2017
Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma.
Journal: Journal of neuro-oncology
Published: May 09, 2016
A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis.
Journal: Oncotarget
Published: April 17, 2016
Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy: A single-institution analysis.
Journal: Urologic oncology
Published: February 16, 2016
Last Updated: 09/26/2026